149 related articles for article (PubMed ID: 9186329)
1. Total prostate and transition zone volumes, and transition zone index are poorly correlated with objective measures of clinical benign prostatic hyperplasia.
Lepor H; Nieder A; Feser J; O'Connell C; Dixon C
J Urol; 1997 Jul; 158(1):85-8. PubMed ID: 9186329
[TBL] [Abstract][Full Text] [Related]
2. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.
Corica FA; Jacobsen SJ; King BF; Bostwick DG; Jacobson DJ; Girman CJ; Lieber MM
J Urol; 1999 Mar; 161(3):831-4. PubMed ID: 10022695
[TBL] [Abstract][Full Text] [Related]
3. Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure.
Kaplan SA; Te AE; Pressler LB; Olsson CA
J Urol; 1995 Nov; 154(5):1764-9. PubMed ID: 7563342
[TBL] [Abstract][Full Text] [Related]
4. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
Marks LS; Roehrborn CG; Wolford E; Wilson TH
J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
[TBL] [Abstract][Full Text] [Related]
5. Relationships between American Urological Association symptom index, prostate volume, and disease-specific quality of life question in patients with benign prostatic hyperplasia.
Liu CC; Wang CJ; Huang SP; Chou YH; Wu WJ; Huang CH
Kaohsiung J Med Sci; 2004 Jun; 20(6):273-8. PubMed ID: 15253468
[TBL] [Abstract][Full Text] [Related]
6. Correlation of transrectal ultrasound measurements of prostate and transition zone size with symptom score, bother score, urinary flow rate, and post-void residual volume.
Terris MK; Afzal N; Kabalin JN
Urology; 1998 Sep; 52(3):462-6. PubMed ID: 9730461
[TBL] [Abstract][Full Text] [Related]
7. The American Urological Association symptom index for benign prostatic hyperplasia as a function of age, volume and ultrasonic appearance of the prostate.
Kojima M; Naya Y; Inoue W; Ukimura O; Watanabe M; Saitoh M; Watanabe H
J Urol; 1997 Jun; 157(6):2160-5. PubMed ID: 9146607
[TBL] [Abstract][Full Text] [Related]
8. [Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia].
Krivoborodov GG; Efremov NS; Bolotov AD
Urologiia; 2017 Oct; (5):9-14. PubMed ID: 29135135
[TBL] [Abstract][Full Text] [Related]
9. Prostate shape and symptom score in benign prostatic hyperplasia.
Lee T; Seong DH; Yoon SM; Ryu JK
Yonsei Med J; 2001 Oct; 42(5):532-8. PubMed ID: 11675682
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen and transition zone index - powerful predictors for acute urinary retention in men with benign prostatic hyperplasia.
Milonas D; Trumbeckas D
Medicina (Kaunas); 2003; 39(11):1071-7. PubMed ID: 14646460
[TBL] [Abstract][Full Text] [Related]
11. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia.
Kurita Y; Masuda H; Terada H; Suzuki K; Fujita K
Urology; 1998 Apr; 51(4):595-600. PubMed ID: 9586613
[TBL] [Abstract][Full Text] [Related]
12. Correlations among cardiovascular risk factors, prostate blood flow, and prostate volume in patients with clinical benign prostatic hyperplasia.
Chen IH; Tsai YS; Tong YC
Urology; 2012 Feb; 79(2):409-14. PubMed ID: 22137544
[TBL] [Abstract][Full Text] [Related]
13. A statistical study of the American Urological Association symptom index for benign prostatic hyperplasia in participants of mass screening program for prostatic diseases using transrectal sonography.
Ukimura O; Kojima M; Inui E; Ochiai A; Hata Y; Watanabe M; Saitoh M; Watanabe H
J Urol; 1996 Nov; 156(5):1673-8. PubMed ID: 8863568
[TBL] [Abstract][Full Text] [Related]
14. Determination of transition zone volume by transrectal ultrasound in patients with clinically benign prostatic hyperplasia: agreement with enucleated prostate adenoma weight.
Baltaci S; Yagci C; Aksoy H; Elan AH; Gögüs O
J Urol; 2000 Jul; 164(1):72-5. PubMed ID: 10841600
[TBL] [Abstract][Full Text] [Related]
15. Data from frequency-volume charts versus symptom scores and quality of life score in men with lower urinary tract symptoms due to benign prostatic hyperplasia.
van Venrooij GE; Eckhardt MD; Gisolf KW; Boon TA
Eur Urol; 2001 Jan; 39(1):42-7. PubMed ID: 11173938
[TBL] [Abstract][Full Text] [Related]
16. Impact of prostate size on the outcome of transurethral laser evaporation of the prostate for benign prostatic hyperplasia.
Narayan P; Tewari A; Fournier G; Toke A
Urology; 1995 May; 45(5):776-82. PubMed ID: 7538239
[TBL] [Abstract][Full Text] [Related]
17. Transrectal ultrasonic planimetry of the prostate in relation to age and lower urinary tract symptoms among elderly men in Japan.
Taneike R; Kojima M; Saitoh M
Tohoku J Exp Med; 1997 Oct; 183(2):135-50. PubMed ID: 9526804
[TBL] [Abstract][Full Text] [Related]
18. Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins.
Meikle AW; Stephenson RA; Lewis CM; Middleton RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):571-5. PubMed ID: 9024256
[TBL] [Abstract][Full Text] [Related]
19. Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia.
Sciarra A; D'Eramo G; Casale P; Loreto A; Buscarini M; Di Nicola S; Seccareccia F; Di Silverio F
Prostate; 1998 Feb; 34(2):121-8; discussion 129. PubMed ID: 9465943
[TBL] [Abstract][Full Text] [Related]
20. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia.
Marks LS; Partin AW; Gormley GJ; Dorey FJ; Shery ED; Garris JB; Subong EN; Stoner E; deKernion JB
J Urol; 1997 Jun; 157(6):2171-8. PubMed ID: 9146609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
